These outcomes, along with a earlier report displaying that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like conduct in mice,2 aid the principle of focusing on ACKR3 as a unique strategy to modulate the opioid procedure, which could open new therapeutic avenues for opioid-similar disorders.Gene expression Evaluation uncovered that ACK